Eleva’s CEO says CHO cell line alternatives could become common as large molecule drugs become complex and harder to produce ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

Edward Tenthoff is a principal research analyst of Piper Jaffray’s analyst team. He specializes in health care and drug discovery financial research. Mr. Tenthoff spoke with Katharine Herrup of The ...

The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Mike Finelli The way we ...

THE Philippines is on the cusp of a biotechnological revolution, with the potential to transform the country's agriculture, food security, and public health. A recent forum in Manila brought together ...

Get the latest federal technology news delivered to your inbox. Innovation in emerging technologies—from semiconductor manufacturing to biotechnologies—continues to be a priority within the Biden ...

The Ayurvedic industry is rapidly growing, integrating biotechnology to enhance scientific credibility and global acceptance. This fusion employs advanced tools for phytochemical profiling, systems ...

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, ...